Enzymes called proteases act like molecular scissors for proteins in the body and play a role in therapies to stop viruses from replicating and to kill cancer cells. The development of these medicines ...

A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...

Efforts to improve cancer imaging technologies are crucial for diagnosing and treating the disease effectively. This transition from experimental to clinical use requires bridging the gap between ...

Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...

MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.

Spread the loveIn a groundbreaking study, researchers from Sweden have unveiled an artificial intelligence (AI) system capable of predicting the risk of melanoma years before it manifests. This ...

A massive Swedish study shows that AI can spot people at higher risk of melanoma using routine health data. Advanced models ...